Financial Statements

United Therapeutics Corporation (UTHR)

$224.78

-3.61 (-1.58%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 3,8393,3253,4352,846-
Net Income 476514-105589418
Stock Dividends 0-0-5-2,428
Dividend Paid -----
Retained Earnings 4,3153,8393,3253,4352,846

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 731739700546-
Annual Depreciation 17152123338632
Capital Expenditure -121-59-84-184-86
Net PPE 781731739700546

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -143228-
New Purchases -831-862-1,272-2,308-1,895
Intangible and Goodwill 143228-28

United Therapeutics Corporation income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes United Therapeutics Corporation FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.